Novel CD3 Epsilon Immunogens And Antibodies
AssigneeHealth Research, Inc.
InventorsKenneth A. Pass, Barbara Lindau-Shepard, David K. Janik
Life of this patent
Estimating the term…
Abstract
The present invention relates to novel CD3 epsilon peptides, antibodies against the novel CD3 epsilon peptides. The invention also relates to methods of identifying an immunodeficiency (such as severe combined immunodeficiency (SCID) or a T cell immunodeficiency) in a patient, which may involve antibodies against CD3 epsilon peptides.
Claims15
An isolated CD3 epsilon peptide comprising residues 8-12 of SEQ ID NO:
- 1.
An isolated CD3 epsilon peptide comprising residues 6-10 of SEQ ID NO:
- 2.
An isolated CD3 epsilon peptide consisting of 12 residues wherein residues 8-12 of the peptide are residues 8-12 of SEQ ID NO:
- 1.
An isolated CD3 epsilon peptide consisting of 10 residues wherein residues 6-10 of the peptide are residues 6-10 of SEQ ID NO:
- 2.
An isolated CD3 epsilon peptide consisting of SEQ ID NO:
- 1.
An isolated CD3 epsilon peptide consisting of SEQ ID NO:
- 2.
Dependencies are inferred from the claim text.